The human urocortin 2 gene is regulated by hypoxia: Identification of a hypoxia-responsive element in the 3′-flanking region

Biochemical Journal

Volumn 424, Issue 1, 2009, Pages 119-127

  Bühler, Katrin ^a   Plaisance, Isabelle ^a   Dieterle, Thomas ^a,b   Brin, Marijke ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cardiomyocyte; Heart; Hypoxia inducible factor 1; Ischaemia; Transcriptional regulation; Urocortin 2

Indexed keywords

CARDIOMYOCYTE; HEART; HYPOXIA-INDUCIBLE FACTOR 1; ISCHAEMIA; TRANSCRIPTIONAL REGULATION; UROCORTIN 2;

CARDIOVASCULAR SYSTEM; CELL DEATH; GENETIC ENGINEERING; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

CICLOPIROXOLAMINE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2; LUCIFERASE; MESSENGER RNA; UNCLASSIFIED DRUG; UROCORTIN II;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; ENHANCER REGION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; ANTIFUNGAL AGENTS; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; MUTAGENESIS, SITE-DIRECTED; PYRIDONES; RATS; RATS, WISTAR; RESPONSE ELEMENTS; UROCORTINS;

RATTUS;

EID: 71049145363     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090311     Document Type: Article

References (34)

1. Burley, D. S., Hamid, S. A. and Baxter, G. F. (2007) Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev. 12, 279-291
2. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C. et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292
3. Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W. and Sawchenko, P. E. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848
4. Brar, B. K., Jonassen, A. K., Egorina, E. M., Chen, A., Negro, A., Perrin, M. H., Mjos, O. D., Latchman, D. S., Lee, K. F. and Vale, W. (2004) Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145, 24-35
5. Yang, L. Z., Kockskamper, J., Heinzel, F. R., Hauber, M., Walther, S., Spiess, J. and Pieske, B. (2006) Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A. Cardiovasc. Res. 69, 402-411
6. Kageyama, K., Furukawa, K., Miki, I., Terui, K., Motomura, S. and Suda, T. (2003) Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J. Cardiovasc. Pharmacol. 42, 561-565
7. Wiley, K. E. and Davenport, A. P. (2004) CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br. J. Pharmacol. 143, 508-514
8. Chen, A., Blount, A., Vaughan, J., Brar, B. and Vale, W. (2004) Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology 145, 2445-2457
9. Hsu, S. Y. and Hsueh, A. J. (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611
10. Yamauchi, N., Otagiri, A., Nemoto, T., Sekino, A., Oono, H., Kato, I., Yanaihara, C. and Shibasaki, T. (2005) Distribution of urocortin 2 in various tissues of the rat. J. Neuroendocrinol. 17, 656-663
11. Davis, M. E., Pemberton, C. J., Yandle, T. G., Fisher, S. F., Lainchbury, J. G., Frampton, C. M., Rademaker, M. T. and Richards, M. (2007) Urocortin 2 infusion in human heart failure. Eur. Heart J. 28, 2589-2597
12. Bale, T. L., Hoshijima, M., Gu, Y., Dalton, N., Anderson, K. R., Lee, K. F., Rivier, J., Chien, K. R., Vale, W. W. and Peterson, K. L. (2004) The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc. Natl. Acad. Sci. U.S.A. 101, 3697-3702
13. Rademaker, M. T., Cameron, V. A., Charles, C. J. and Richards, A. M. (2005) Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112, 3624-3632
14. Dieterle, T., Meili-Butz, S., Bühler, K., Morandi, C., John, D., Buser, P., Vale, W., Peterson, K. L. and Brink, M. (2009) Immediate and sustained blood pressure lowering by urocortin 2 in hypertensive Dahl rats: a novel approach to antihypertensive therapy? Hypertension 53, 739-744
15. Chanalaris, A., Lawrence, K. M., Stephanou, A., Knight, R. D., Hsu, S. Y., Hsueh, A. J. and Latchman, D. S. (2003) Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. J. Mol. Cell. Cardiol. 35,, 1295-1305
16. Springhorn, J. P. and Claycomb, W. C. (1989) Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem. J. 258, 73-78
17. Chen, A., Vaughan, J. and Vale, W. W. (2003) Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Mol. Endocrinol. 17, 1622-1639
18. Linden, T., Katschinski, D. M., Eckhardt, K., Scheid, A., Pagel, H. and Wenger, R. H. (2003) The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis. FASEB J. 17, 761-763
19. Beck, I., Ramirez, S., Weinmann, R. and Caro, J. (1991) Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J. Biol. Chem. 266, 15563-15566
20. Pescador, N., Cuevas, Y., Naranjo, S., Alcaide, M., Villar, D., Landazuri, M. O. and Del Peso, L. (2005) Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390, 189-197
21. Minchenko, O., Opentanova, I., Minchenko, D., Ogura, T. and Esumi, H. (2004) Hypoxia induces transcription of 6-phosphofructo-2-kinase/ fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1α activation. FEBS Lett. 576, 14-20
22. Cummins, E. P. and Taylor, C. T. (2005) Hypoxia-responsive transcription factors. Pflugers Arch. 450, 363-371
23. 2-regulated prolyl hydroxylation. Science 292, 468-472
24. Semenza, G. L. (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7, 345-350
25. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D. and Pouyssegur, J. (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082-4090
26. Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P., Maire, P. and Giallongo, A. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529-32537
27. Sanchez-Elsner, T., Ramirez, J. R., Sanz-Rodriguez, F., Varela, E., Bernabeu, C. and Botella, L. M. (2004) A cross-talk between hypoxia and TGF-β orchestrates erythropoietin gene regulation through SP1 and Smads. J. Mol. Biol. 336, 9-24
28. Gupta, M. and Goldwasser, E. (1996) The role of the near upstream sequence in hypoxia-induced expression of the erythropoietin gene. Nucleic Acids Res. 24, 4768-4774
29. Simon, M. P., Tournaire, R. and Pouyssegur, J. (2008) The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J. Cell Physiol. 217, 809-818
30. Yamashita, K., Discher, D. J., Hu, J., Bishopric, N. H. and Webster, K. A. (2001) Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 276, 12645-12653
31. Schofield, C. J. and Ratcliffe, P. J. (2004) Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343-354
32. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96, 1173-1177
33. Rizvi, A., Tang, X. L., Qiu, Y., Xuan, Y. T., Takano, H., Jadoon, A. K. and Bolli, R. (1999) Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning. Am. J. Physiol. 277, H874-H884
34. Lei, L., Mason, S., Liu, D., Huang, Y., Marks, C., Hickey, R., Jovin, I. S., Pypaert, M., Johnson, R. S. and Giordano, F. J. (2008) Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol. Cell. Biol. 28, 3790-3803